Skip to content

Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients

Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07649876
Enrollment
30
Registered
2026-06-16
Start date
2026-06-02
Completion date
2026-09-01
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Agitation Associated With Critical Illness, Anxiety Acute, Delirium in the Intensive Care Unit, Sleep Quality in Adult ICU Patients

Keywords

Virtual reality, Intensive care unit, Pain, Agitation, Anxiety, Sleep Quality

Brief summary

This is a pilot feasibility study examining the use of immersive virtual reality (VR) in adult intensive care unit (ICU) patients. The study evaluates whether brief, non-interactive VR sessions delivered using a commercially available standalone head-mounted display with calming, nature-based content can be delivered safely and effectively within routine SICU workflow. Exploratory objectives assess whether VR sessions are associated with changes in anxiety, agitation, delirium, pain, and sedative medication requirements. This research is not intended to evaluate the safety or effectiveness of the headset and/or the specific VR software used for the research

Interventions

VR sessions will use a commercially available headset with non-interactive, immersive content displaying calming nature-based content (e.g., ocean/beach scenes, forests, mountains) delivered through a commercially available VR application

Sponsors

Milton S. Hershey Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

1. Aged ≥ 18 years old admitted to the Surgical Intensive Care Unit (SICU) at Penn State Health Milton S. Hershey Medical Center. 2. No significant uncorrectable visual or auditory impairments 3. Estimated ICU length of stay \> 48h 4. At the time of each VR session, able to keep eyes open for at least 30 seconds, follow simple commands and able to indicate discomfort or request to stop. 5. English speaking

Exclusion criteria

1. Significant hemodynamic instability 2. Known psychotic disorders associated with delusions (e.g. schizophrenia) 3. Severe dementia (e.g. inability to communicate or follow simple commands) 4. History of disequilibrium syndrome or vertigo 5. Acute hyperactive delirium, requiring physical restraints

Design outcomes

Primary

MeasureTime frame
Feasibility of Intervention Measure (FIM)From time of enrollment to end of intervention at 3 days
Acceptability of Intervention Measure (AIM)From time of enrollment to end of intervention at 3 days
Intervention Appropriateness Measure (IAM)From time of enrollment to end of intervention at 3 days

Countries

United States

Contacts

CONTACTPauline H Go, MD
paulinego@pennstatehealth.psu.edu717-531-5429
CONTACTAleksandr Davtyan
adavtyan@pennstatehealth.psu.edu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026